Skip to content
DERMJourney Medical Corp

Earnings

When Journey Medical Corp reports, what it reported each quarter, and how the stock took the results.

25 quarters. Sep 30, 2020 to Sep 30, 2026. USD.

Next results · Q4 2026Projected

Mar 24, after the close

Wed, Mar 24, 2027in 126 days

Projected from its last 8 releases. The company has not named the day yet.

Quarter
Q4 2026 · Ends about Dec 31, 2026
10-K window
Mar 23 – Apr 2

Read against Q4 2025

The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.

Revenue
$16.69M
Revenue, change from a year earlier: Q3 2026 +11.2%, Q2 2026 +18.9%, Q1 2026 +21.2%, Q4 2025 +22.5%
Net income
-$1.25M
Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m
EPS
—
EPS, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m

Quarter by quarter

Q3 2026$18.93M+11.2% vs Q3 2025

Latest results

  1. Q3 2026Nov 12, 2026, after the closeThe release
    Revenue
    $18.93M
    +11.2%
    Net income
    -$1.32M
    N/M
    EPS
    -$0.05
    N/M
    On November 12, 2026, Journey Medical Corporation issued a press release to provide a corporate update and to announce its financial results for the three months ended September 30, 2026.
  2. Q2 2026Aug 12, 2026, after the closeThe release+3.8%by the close of Aug 13
    Revenue
    $17.84M
    +18.9%
    Net income
    -$312.00K
    N/M
    EPS
    -$0.01
    N/M
  3. Q1 2026May 13, 2026, after the closeThe release+23.1%by the close of May 14
    Revenue
    $15.92M
    +21.2%
    Net income
    -$2.23M
    N/M
    EPS
    -$0.08
    N/M
  4. Q4 2025Mar 25, 2026, after the closeThe release30.1%by the close of Mar 26
    Revenue
    $16.69M
    +22.5%
    Net income
    -$1.25M
    N/M
    EPS
    —
    —

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2026
Q3 2026Sep 30, 2026Nov 12, 2026 · after-hoursNov 12, 202643 d10-Q$18.93M+11.2%-$0.05—
Q2 2026Jun 30, 2026Aug 12, 2026 · after-hoursAug 12, 202643 d10-Q$17.84M+18.9%-$0.01+3.8%
Q1 2026Mar 31, 2026May 13, 2026 · after-hoursMay 13, 202643 d10-Q$15.92M+21.2%-$0.08+23.1%
FY 2025
Q4 2025derivedDec 31, 2025Mar 25, 2026 · after-hoursMar 26, 202685 d10-K$16.69M+22.5%—30.1%
Q3 2025Sep 30, 2025Nov 12, 2025 · after-hoursNov 12, 202543 d10-Q$17.03M+16.4%-$0.0915.1%
Q2 2025Jun 30, 2025Aug 12, 2025 · after-hoursAug 12, 202543 d10-Q$15.01M+1.0%-$0.1614.7%
Q1 2025Mar 31, 2025May 14, 2025 · after-hoursMay 15, 202545 d10-Q$13.14M+0.8%-$0.18+17.4%
FY 2024
Q4 2024derivedDec 31, 2024Mar 26, 2025 · after-hoursMar 27, 202586 d10-K$13.62M−10.7%—3.6%
Q3 2024Sep 30, 2024Nov 12, 2024 · after-hoursNov 12, 202443 d10-Q$14.63M−4.3%-$0.124.4%
Q2 2024Jun 30, 2024Aug 12, 2024 · after-hoursAug 13, 202444 d10-Q$14.86M−12.4%-$0.174.4%
Q1 2024Mar 31, 2024May 13, 2024 · after-hoursMay 14, 202444 d10-Q$13.03M+7.1%-$0.53+1.1%
Earlier years, FY 2020 to FY 2023

Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Source filings

10-QNov 12, 2026126285
10-QAug 12, 2026094948
10-QMay 13, 2026060297
10-KMar 26, 2026034629
10-QNov 12, 2025110457
10-QAug 12, 2025001703
10-QMay 15, 2025001296
10-KMar 27, 2025000490
10-QNov 12, 2024001877
10-QAug 13, 2024001326

Provenance

ProvenanceData status and checks

Journey Medical Corp · CIK 1867066 · Engraved from SEC EDGAR